CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Non-Current Assets | ₹857 Cr | ₹591 Cr | ₹541 Cr | ₹299 Cr |
What is the latest Total Non-Current Assets ratio of CORONA REMEDIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹857 Cr |
| Mar2025 | ₹591 Cr |
| Mar2024 | ₹541 Cr |
| Mar2023 | ₹299 Cr |
How is Total Non-Current Assets of CORONA REMEDIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹857 Cr | 44.98 | |
| Mar2025 | ₹591 Cr | 9.31 | |
| Mar2024 | ₹541 Cr | 80.65 | |
| Mar2023 | ₹299 Cr | - | |
Compare Total Non-Current Assets of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,890.3 Cr | -2.7% | 1.8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -2.7% |
1.8% |
|
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses